Dammen Toril, Tunheim Kristoffer, Munkhaugen John, Papageorgiou Costas
Department of Behavioural Medicine, Faculty of Medicine, Insitute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.
Front Psychol. 2022 Jul 27;13:948081. doi: 10.3389/fpsyg.2022.948081. eCollection 2022.
Depression and anxiety symptoms are highly prevalent in coronary heart disease (CHD) patients and associated with poor outcome. Most psychological treatments have shown limited effectiveness on anxiety and depression in these patients. This study evaluates the feasibility of the attention training technique (ATT) in CHD patients with symptoms of anxiety and/or depression.
Five consecutive CHD patients with significant depression and anxiety symptoms with Hospital Anxiety and Depression rating scale (HADS) -anxiety or -depression subscale score > 8 received 6 weekly group-sessions of ATT in an open trial. Outcomes included feasibility and symptoms measured by HADS, at baseline, post-treatment and at 6 months follow-up. We also assessed psychiatric diagnoses, type D personality, insomnia, worry, and rumination.
The sample comprised five men with a mean age of 59.9 (SD 4.4) years. Four of the patients attended all six sessions, and one patient attended all but one session. Mean HADS-A scores at baseline, post-treatment, and follow-up were 9.4 (SD 3.0), 4.2 (SD 3.0), and 4.0 (SD 2.5), and for HADS-D 8.6 (SD 3.3), 3.0 (SD 3.7), and 1.6 (SD 1.5), respectively. The results showed clinically significant changes in anxiety, depression, psychiatric disorders, insomnia, worry, and rumination. Statistically significant changes were found from pre- to post-treatment scores for HADS-A and worry, which were maintained at follow-up, and HADS-D scores significantly decreased from pre-treatment to 6-months follow-up.
ATT in a group format appears to be a feasible stand-alone metacognitive treatment for CHD patients. An adequately powered randomized controlled trial is warranted.
抑郁和焦虑症状在冠心病(CHD)患者中非常普遍,且与不良预后相关。大多数心理治疗对这些患者的焦虑和抑郁效果有限。本研究评估注意力训练技术(ATT)在伴有焦虑和/或抑郁症状的冠心病患者中的可行性。
在一项开放性试验中,连续5例伴有明显抑郁和焦虑症状(医院焦虑抑郁量表(HADS)-焦虑或-抑郁子量表得分>8)的冠心病患者接受了为期6周的ATT小组治疗。观察指标包括可行性以及通过HADS在基线、治疗后和6个月随访时测量的症状。我们还评估了精神科诊断、D型人格、失眠、担忧和沉思。
样本包括5名男性,平均年龄59.9(标准差4.4)岁。4名患者参加了所有6次治疗,1名患者除1次外参加了所有治疗。HADS-A在基线、治疗后和随访时的平均得分分别为9.4(标准差3.0)、4.2(标准差3.0)和4.0(标准差2.5),HADS-D的平均得分分别为8.6(标准差3.3)、3.0(标准差3.7)和1.6(标准差1.5)。结果显示焦虑、抑郁、精神障碍、失眠、担忧和沉思有临床显著变化。HADS-A和担忧从治疗前到治疗后的得分有统计学显著变化,且在随访时保持不变,HADS-D得分从治疗前到6个月随访时显著降低。
小组形式的ATT似乎是一种对冠心病患者可行的独立元认知治疗方法。有必要进行一项样本量充足的随机对照试验。